How Investors Are Reacting To Healthcare Realty Trust (HR) Asset Sales, Profit Return, And 2026 EPS Outlook

Simply Wall St

Tue, February 17, 2026 at 3:10 PM GMT+9 4 min read

In this article:

HR

+2.69%

In the fourth quarter of 2025, Healthcare Realty Trust reported revenue of US$286.3 million, returned to a net profit of US$14.39 million from a prior loss, and approved a US$0.24 per share dividend payable in March 2026 while issuing 2026 EPS guidance between a loss of US$0.05 and a profit of US$0.05 per share.

The company’s year featured US$1.2 billion of asset sales, 5.5% same-store NOI growth in the fourth quarter, stronger leasing and tenant retention, lower leverage at 5.4x net debt to EBITDA, and a new US$600 million commercial paper program that increased funding flexibility for redevelopment and other investments.

Against this backdrop, we’ll explore how Healthcare Realty Trust’s US$1.2 billion asset sales and balance sheet reshaping affect its broader investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Healthcare Realty Trust Investment Narrative Recap

To own Healthcare Realty Trust, you need to believe its shift toward a leaner, outpatient focused portfolio can translate operational gains into steadier earnings, despite recent losses and modest 2026 EPS guidance. The latest quarter showed a return to profitability and healthier leverage, but the key near term catalyst remains execution on leasing and redevelopment, while the biggest risk is that operational improvements and cost savings fail to materialize at the pace needed to support earnings.

Among the recent announcements, the US$1.2 billion of asset sales and resulting reduction in net debt to EBITDA to 5.4x look most relevant, as they directly address prior concerns about leverage and balance sheet flexibility. This stronger footing supports Healthcare Realty’s ability to fund redevelopment and lease up projects, which sit at the heart of the earnings improvement thesis, even as 2026 EPS guidance signals a relatively flat near term profit outlook.

But against that progress, investors should also understand how much the thesis still depends on successful execution of the company’s operational overhaul and capital investment program…

Read the full narrative on Healthcare Realty Trust (it’s free!)

Healthcare Realty Trust’s narrative projects $1.2 billion revenue and $275.4 million earnings by 2028.

Uncover how Healthcare Realty Trust’s forecasts yield a $19.10 fair value, a 6% upside to its current price.

Story Continues  

Exploring Other Perspectives

HR 1-Year Stock Price Chart

Two fair value estimates from the Simply Wall St Community currently span roughly US$19.10 to about US$27.71 per share, underscoring how far apart individual views can be. Set against this wide range, the company’s recent balance sheet reshaping and focus on outpatient assets give you concrete developments to weigh as you explore different opinions on Healthcare Realty’s future performance.

Explore 2 other fair value estimates on Healthcare Realty Trust - why the stock might be worth just $19.10!

Reach Your Own Conclusion

Don’t just follow the ticker - dig into the data and build a conviction that’s truly your own.

A great starting point for your Healthcare Realty Trust research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.

Our free Healthcare Realty Trust research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Healthcare Realty Trust's overall financial health at a glance.

Want Some Alternatives?

Don’t miss your shot at the next 10-bagger. Our latest stock picks just dropped:

Find 54 companies with promising cash flow potential yet trading below their fair value.

Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include HR.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info